Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy

Diabetes Research and Clinical Practice

Volumn 58, Issue 2, 2002, Pages 123-129

  Takahashi, Takeshi ^a   Yano, Miyuki ^a   Minami, Junko ^a   Haraguchi, Tomoko ^a   Koga, Naoko ^a   Higashi, Kiichiro ^a   Kobori, Shozo ^a  

^a NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Microalbuminuria; Serotonin; Serotonin2A receptor antagonist; Type 2 diabetes mellitus

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALBUMIN; HEMOGLOBIN A1C; SARPOGRELATE; SEROTONIN 2A ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPHYLAXIS; PROTEIN URINE LEVEL; SIDE EFFECT; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; REFERENCE VALUES; REGRESSION ANALYSIS; SEROTONIN; SEROTONIN ANTAGONISTS; SUCCINATES; TIME FACTORS;

EID: 0036837092     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00105-5     Document Type: Article

References (12)

1. Tyce G.M. Origin and metabolism of serotonin. J. Cardio. Pharmacol. 16:1990;1-7.
2. Barradas M.A., Gill D.S., Fonseca V.A., Mikhailidis D.P., Dandona P. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur. J. Clin. Invest. 18:1988;399-404.
3. Malyszko J., Urano T., Knofler R., Taminato A., Takeda Y., Takada A. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thromb. Res. 75:1994;569-576.
4. 2A receptor. Am. J. Physiol. 268:1995;F122-F127.
5. Mauer S.M., Steffes M.W., Ellis E.N., Sutherland D.E.R., Brown D.M., Goetz F.C. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74:1984;1143-1155.
6. Kasyo M., Sakai M., Sasahara T., et al. Serotonin enhances the production of type IV collagen by human mesangial cells. Kidney Int. 54:1998;1083-1092.
7. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N. Engl. J. Med. 310:1984;56-60.
8. Teppo A.M. Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin. Chem. 28:1982;1359-1361.
9. Kunst A., Draeger B., Ziegenhorn J. Colorimetric methods with glucose oxidase and peroxidase. Berbmeyer H.U. 3rd ed. Methods of Enzymatic Analysis. 6: 1984;178-185 Verlag Chemie Weinheim.
10. Khuu H.M., Robinson C.A., Goolsby K., Hardy R.W., Konrad R.J. Evaluation of a fully automated high-performance liquid chromatography assay for hemoglobin A1c. Arch. Pathol. Lab. Med. 123:1999;763-767.
11. Helander A., Beck O., Wennberg M., Wikstrom T., Jacobssen G. Determination of urinary 5-hydroxyindole-3-acetic acid by high-performance liquid chromatography with electrochemical detection and direct sample injection. Anal. Biochem. 196:1991;170-173.
12. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28:1995;103-117.